Trademark Search in Canada

VONJO

View On IC.GC.CA

REGISTERED

on 6 Sept 2023

Last Applicant/ Owned by

SOBI, INC

77 4th Avenue, 3rd FloorWaltham MA 02451

Serial Number

2135364 filed on 20^th Jul 2021

Registration Number

TMA1197013 registered on 6^th Sept 2023

Registration expiry Date

20^th Jul 2031

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

2900 - 550 BURRARD STREETVANCOUVER

BRITISH COLUMBIA

V6C0A3

VONJO

Trademark usage description

pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and preve Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.

Classification kind code

Class [044]
Providing healthcare information concerning of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.

Classification kind code

Mark Details

Serial Number

2135364

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 10^th Jan 2023	Search Recorded
Submitted for opposition 20 on 10^th Jan 2023	Examiner's First Report
Submitted for opposition 223 on 10^th Jan 2023	Total Provisional Refusal
Submitted for opposition 256 on 25^th Jul 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 6^th Dec 2021	Agent Changed
Submitted for opposition 257 on 23^rd Sept 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 23^rd Sept 2021	Formalized
Submitted for opposition 1 on 23^rd Sept 2021	Created
Submitted for opposition 228 on 20^th Jul 2021	International Registration
Submitted for opposition 30 on 20^th Jul 2021	Filed

VONJO

Classification Information

Class [005]Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.

Classification kind code

Class [044]Providing healthcare information concerning of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.

Class [044]
Providing healthcare information concerning of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.